Life Healthcare Statistics
Share Statistics
Life Healthcare has -
shares outstanding. The number of shares has increased by 2.1%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 2.1% |
| Shares Change (QoQ) | 2.1% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 164 |
| FTD / Avg. Volume | 0.34% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 11.49 and the forward
PE ratio is null.
Life Healthcare's PEG ratio is
0.05.
| PE Ratio | 11.49 |
| Forward PE | n/a |
| PS Ratio | 2.17 |
| Forward PS | n/a |
| PB Ratio | 4.42 |
| P/FCF Ratio | 25.56 |
| PEG Ratio | 0.05 |
Financial Ratio HistoryEnterprise Valuation
Life Healthcare has an Enterprise Value (EV) of 223.84B.
| EV / Sales | 8.77 |
| EV / EBITDA | 50.61 |
| EV / EBIT | 60.12 |
| EV / FCF | 103.15 |
Financial Position
The company has a current ratio of 1.43,
with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.43 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 1 |
| Debt / FCF | 2.04 |
| Interest Coverage | 6.87 |
Financial Efficiency
Return on Equity is 38.5% and Return on Invested Capital is 11.58%.
| Return on Equity | 38.5% |
| Return on Assets | 19.83% |
| Return on Invested Capital | 11.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 1.05 |
| Inventory Turnover | 16.55 |
Taxes
| Income Tax | 538M |
| Effective Tax Rate | 19.73% |
Stock Price Statistics
The stock price has increased by 47% in the
last 52 weeks. The beta is 0.08, so Life Healthcare's
price volatility has been higher than the market average.
| Beta | 0.08 |
| 52-Week Price Change | 47% |
| 50-Day Moving Average | 3.03 |
| 200-Day Moving Average | 3.32 |
| Relative Strength Index (RSI) | 57.36 |
| Average Volume (20 Days) | 48,662 |
Income Statement
In the last 12 months, Life Healthcare had revenue of 25.52B
and earned 4.83B
in profits. Earnings per share was 2.28.
| Revenue | 25.52B |
| Gross Profit | 17.81B |
| Operating Income | 2.9B |
| Net Income | 4.83B |
| EBITDA | 4.42B |
| EBIT | 3.15B |
| Earnings Per Share (EPS) | 2.28 |
Full Income StatementBalance Sheet
The company has 2.46B in cash and 4.42B in
debt, giving a net cash position of -1.96B.
| Cash & Cash Equivalents | 2.46B |
| Total Debt | 4.42B |
| Net Cash | -1.96B |
| Retained Earnings | -333M |
| Total Assets | 24.34B |
| Working Capital | 2.27B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 3.72B
and capital expenditures -1.55B, giving a free cash flow of 2.17B.
| Operating Cash Flow | 3.72B |
| Capital Expenditures | -1.55B |
| Free Cash Flow | 2.17B |
| FCF Per Share | 0.62 |
Full Cash Flow StatementMargins
Gross margin is 69.78%, with operating and profit margins of 11.36% and 18.92%.
| Gross Margin | 69.78% |
| Operating Margin | 11.36% |
| Pretax Margin | 10.69% |
| Profit Margin | 18.92% |
| EBITDA Margin | 17.33% |
| EBIT Margin | 11.36% |
| FCF Margin | 8.5% |
